Results

Total Results: 1,636 records

Showing results for "treated".

301. Hip-Fracture-Pain Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hip-fracture-pain_clinician.pdf
     May 01, 2011 - . ��� Adverse Events Overall, adverse event rates were similar in both treated and control groups,

302. Imaging Tests To Check for Kidney Stones in the Emergency Department (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-stone-imaging_consumer.pdf
     July 01, 2016 - stone that becomes stuck may cause pain that does not go away and may damage the kidney if it is not treated

303. Behavioral Programs To Help Manage Type 2 Diabetes: A Review of the Research for Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_consumer.pdf
     November 01, 2016 - If not treated right away, hypoglycemia can be life threatening.

304. Behavioral Programs To Help Manage Type 1 Diabetes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_consumer-2016.pdf
     January 01, 2016 - If not treated right away, hypoglycemia can be life threatening.

305. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/14_substanceabuse_potential_high_impact_june_2012.pdf
     January 01, 2012 - #14 SUBSTANCE ABUSE AHRQ Healthcare Horizon Scanning System – Potential High Impact Interventions Report Priority Area 14: Substance Abuse Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.a…

306. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_disposition-comments.pdf
     March 10, 2010 - significant cardiovascular risk remains in numerous patients, even after LDL-C has been optimally treated

307. Functional-Limitations-Horizon-Scan-High-Impact-1306 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - were encouraged by the lower relapse rates and delayed disease progression reported in patients treated … Researchers stated that patients treated with icatibant reported significantly faster initial symptom … Five patients treated with icatibant reported treatment-related adverse events that included diarrhea … , nausea, dyspepsia, headache, and injection- site erythema; no patient treated with icatibant experienced … and the United States.62 Both trials met the primary endpoints, with 26.4% of the 465 ocriplasmin-treated

308. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research-protocol.pdf
     November 16, 2010 - 2010 for screening for glaucoma will consider and compare, where possible, whether patients were treated … or not treated for early stages of glaucoma. … subgroup analysis of studies that include asymptomatic participants who have been previously tested or treated

309. S116 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s116.pdf
     October 01, 2007 - This association disappeared when the study was restricted to the patients treated by primary care physicians … These patients were treated by 6390 physicians. … psychiatric conditions such as anxiety or panic disor- ders, and alcohol dependency that are typically treated

310. Type-2-Diabetes-Medications-Update Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_surveillance.pdf
     December 31, 2013 - unpublished findings by a that suggest pre-cancerous cellular changes in type 2 diabetes patients treated … Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type … More patients treated with sitagliptin/metformin had an HbA1c value <7% (p < 0.001) versus metformin … Hypoglycemia occurred in three patients (0.6%) treated with linagliptin and five patients (2.8%) in … More saxagliptin-treated patients achieved a HbA1c < 7.0% (46.5% versus 30.5%; p = 0.0001).

311. Draft - Primary Hypofractionated Radiation Therapy for Localized Prostate Cancer: Appendix D1 Tables (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-draft-appendix-d1.xlsx
     January 01, 2024 - for 1 month after treatment Spain Not reported NR Patients with localized prostate cancer who were treated … therapy; prior or active malignancy other than nonmelanoma skin cancer, colon cancer, or thyroid cancer treated … Academic,Non-academic Multiple Intermediate-risk prostate cancer, treated with SBRT 2005 to 2015 NR 2214

312. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pelvic-pain-surveillance-151130.pdf
     July 10, 2015 - Patient populations must include adult women (≥ 18 years of age) being treated for CPP; studies with … Women treated with progestogen reported more adverse effects (e.g. weight gain, bloating) than those … Women treated with progestogen reported more adverse effects (e.g. weight gain, bloatedness) than those … Women treated with progestogen reported more adverse effects (e.g. weight gain, bloating) than those … Search (July 2015) Expert Opinion Surveillance Assessment to report improved pain than those treated

313. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1406.pdf
     January 01, 2020 - Treatment of Opioid Overdose by Nonclinicians Unmet need: Opioid overdoses can be fatal when not treated

314. Comparative Effectiveness of Therapies for Women with Noncyclic Chronic Pelvic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pelvic-pain_disposition-comments.pdf
     January 01, 2012 - pain referred from the sacroiliac joint(s) is a common pain generator, that is poorly diagnosed or treated … I have treated approx 30K patients with these sorts of disorders.

315. Disposition of Comments Report for Comparative Effectiveness of Bariatric Surgery and Nonsurgical Therapy in Adults With Metabolic Conditions and a Body Mass Index of 30.0 to 34.9 kg/m2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/weight-loss-surgery_disposition-comments.pdf
     June 05, 2013 - Disposition of Comments Report for Comparative Effectiveness of Bariatric Surgery and Nonsurgical Therapy in Adults With Metabolic Conditions and a Body Mass Index of 30.0 to 34.9 kg/m2 Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Comparative Effectiveness …

316. Since their introduction in 20xx, DES have been shown in clinical trials to decrease TLR (… (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/coronary-stents-outcomes_research.pdf
     January 01, 2010 - intervention on ACC/AHA Type C lesion, PCI status of urgent or STEMI, intervention in a previously treated … of the composite endpoints tracked closely with its individual components, favoring DES over BMS treated … P res pec ified Outc omes Death Prior analyses comparing survival in DES and BMS treated patients … incomplete, it is reflective of populations known to be absent from the Medicare data set such as patients treated … 1.451 Highest Risk Segment in Graft 0.804 0.702 0.920 Lesion Risk 1.018 0.993 1.044 Previously Treated

317. Disposition of Comments Report for CER 134 Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse-drug-therapy_disposition-comments.pdf
     May 13, 2014 - When including all studies, subjects treated with naltrexone had 3.8 percent fewer heavy drinking days … than those treated with placebo (WMD, -3.8; 95% CI, -5.8 to -1.8; 11 trials); when excluding 3 studies … Patients treated with 380 mg extended release naltrexone (VIVITROL) experienced approximately a 25% … patients, those treated with VIVITROL 380 mg were more likely than placebo-treated patients to maintain … Patients treated with 380 mg extended release naltrexone (VIVITROL) experienced approximately a 25%

318. Slide 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/johnson_-ahrq-mcda-presentation.pdf
     August 27, 2012 - Slide 1 Research Triangle Institute RTI International is a trade name of Research Triangle Institute. www.rti.org The Use of Conjoint Analysis to Elicit Patient Preferences in Selecting Treatment Endpoints F. Reed Johnson, PhD Distinguished Fellow and Principal Economist Research Triangle Institute I…

319. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/migraine-prevention_research-protocol.pdf
     November 03, 2011 - Treated and relieved by triptan(s) or ergot before the expected development of C.1 above D.

320. Disposition of Comments Report for CER 132 Combination Therapy Versus Intensification of Statin Monotherapy: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_disposition-comments.pdf
     September 01, 2014 - a direct measure of atherosclerosis) was unchanged over the course of the study in the ezetimibe-treated … with niacin, this presumed benefit was not reflected in improved clinical outcomes among patients treated … The 2009 AHRQ review found no difference in SAEs between patients treated with statins and those treated … (Carotid Intimal Thickness, HDL and Non-HDL cholesterol goals), with acceptable risk profiles in treated … Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs.